Cargando…
OnabotulinumtoxinA affects cortical recovery period but not occurrence or propagation of cortical spreading depression in rats with compromised blood–brain barrier
OnabotulinumtoxinA (BoNT-A) is an Food and Drug Administration-approved, peripherally acting preventive migraine drug capable of inhibiting meningeal nociceptors. Expanding our view of how else this neurotoxin attenuates the activation of the meningeal nociceptors, we reasoned that if the stimulus t...
Autores principales: | Melo-Carrillo, Agustin, Strassman, Andrew M., Schain, Aaron J., Broide, Ron S., Cai, Brian B., Rhéaume, Catherine, Brideau-Andersen, Amy D., Ashina, Sait, Flores-Montanez, Yadira, Brin, Mitchell F., Burstein, Rami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374711/ https://www.ncbi.nlm.nih.gov/pubmed/34448754 http://dx.doi.org/10.1097/j.pain.0000000000002230 |
Ejemplares similares
-
Combined onabotulinumtoxinA/atogepant treatment blocks activation/sensitization of high-threshold and wide-dynamic range neurons
por: Melo-Carrillo, Agustin, et al.
Publicado: (2020) -
Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats
por: Melo-Carrillo, Agustin, et al.
Publicado: (2019) -
Botox (onabotulinumtoxinA) mechanism of action
por: Brin, Mitchell F., et al.
Publicado: (2023) -
OnabotulinumtoxinA alters inflammatory gene expression and immune cells in chronic headache patients
por: Gfrerer, Lisa, et al.
Publicado: (2021) -
OnabotulinumtoxinA effects on trigeminal nociceptors
por: Moore, Ashley A, et al.
Publicado: (2023)